Convatec expects up to 5.5 percent growth in 2022
The annual report from British medtech firm Convatec has just been released, containing an organic growth guidance of 4–5.5 percent for 2022.
By marketwire, translated by daniel pedersen
British medtech firm Convatec has released its annual report for 2021.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Convatec upgrades 2021 sales forecast
For subscribers
Coloplast starts share buyback program
For subscribers
Smith & Nephew releases full-year report, appoints new CEO
For subscribers
